140 related articles for article (PubMed ID: 32322091)
21. Does dapsone resistance really matter in the MDT era?
Ji B
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
[No Abstract] [Full Text] [Related]
22. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
23. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
[TBL] [Abstract][Full Text] [Related]
24. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Ji B; Perani EG; Petinom C; Grosset JH
Antimicrob Agents Chemother; 1996 Feb; 40(2):393-9. PubMed ID: 8834886
[TBL] [Abstract][Full Text] [Related]
25. Study of antileprosy activities of some dialkyldithiocarbamate derivatives.
Urlyapova NG; Yushchenko AA; Daudova AD; Makarov VA
Bull Exp Biol Med; 2007 Mar; 143(3):356-8. PubMed ID: 18225763
[TBL] [Abstract][Full Text] [Related]
26. In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
Ishihara S; Hagiwara S; Fujuda T
Microbios; 1977; 19(76):117-23. PubMed ID: 366337
[TBL] [Abstract][Full Text] [Related]
27. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
28. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
Waters MF; Pearson JM; Rees RJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
[No Abstract] [Full Text] [Related]
29. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Soares DJ; Neupane K; Britton WJ
Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
Dhople AM; Lamoureux LC; Gardner GD
Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
[TBL] [Abstract][Full Text] [Related]
31. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
[TBL] [Abstract][Full Text] [Related]
32. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy.
Matsuoka M; Kashiwabara Y; Liangfen Z; Goto M; Kitajima S
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):240-3. PubMed ID: 14608820
[TBL] [Abstract][Full Text] [Related]
33. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
Chang YT
Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
[TBL] [Abstract][Full Text] [Related]
34. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
35. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
Raj PP; Aschhoff M; Lilly L; Balakrishnan S
Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
[TBL] [Abstract][Full Text] [Related]
36. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
Dhople AM; Ortega I; Seydel JK; Gardner GD
Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
[TBL] [Abstract][Full Text] [Related]
37. [EXPERIMENTAL STUDY OF SPECIFIC ACTIVITY OF 1.3-DIAZINON-4 COM- POUND PYaTd1 DERIVATIVE IN VIVO].
Luzhnova SA; Yushin MY; Voronkov AV; Osychenko SA; Gabitova NM; Yurtaeva EA
Zh Mikrobiol Epidemiol Immunobiol; 2016 Sep; (5):18-22. PubMed ID: 30695344
[TBL] [Abstract][Full Text] [Related]
38. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
Millan J; Moulia-Pelat JP
Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
[TBL] [Abstract][Full Text] [Related]
39. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
40. The immunopharmacology of antileprosy agents.
Anderson R
Lepr Rev; 1983 Jun; 54(2):139-44. PubMed ID: 6350776
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
